AOD-9604 doesnt fit into this stack mechanistically, since its entire research premise is isolating fat metabolism from GH activity rather than amplifying it, which is why its more often discussed as an alternative to this combination than a companion to it
Practitioners recommend bi-weekly treatments over approximately three months [16] , though individual treatment plans may vary based on specific health needs and goals
The peptides selective mechanism distinguishes it from broader-acting hormonal therapies with more complex side effect profiles
Your provider makes the call during your assessment, weighing your history, labs, and goals
Clinical Evidence & Research Findings The published research behind AOD-9604 and Tesamorelin tells two very different stories: AOD-9604s early efficacy signal didnt hold up in its largest trial, while Tesamorelins did which is the central reason one reached FDA approval and the other didnt